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Objective: To investigate the effect of the roselle calyx extract (RCE) (Hibiscus sab-
dariffa L.) on the in vitro viability and bioﬁlm formation ability of oral pathogenic
bacteria.
Methods: RCE was prepared by soaking roselle calyx powder with ethyl alcohol for
24 h at room temperature. After centrifugation, the extract was lyophilized. Then, the
extract was dissolved in phosphate-buffered saline, the pH was adjusted, and the extract
was aseptically ﬁltered. We used Streptococcus mutans, Streptococcus sanguinis,
Lactobacillus casei, Actinomyces naeslundii, Aggregatibacter actinomycetemcomitans,
Fusobacterium nucleatum, Porphyromonas gingivalis and Prevotella intermedia in this
study. The antibacterial activity of the RCE was determined by treating the cells of these
bacteria with the extract for 10 or 20 min at room temperature. The minimum inhibitory
concentration (MIC) and minimum bactericidal concentration was determined using the
microdilution method, and the effect of the RCE on the ability to form bioﬁlm was
determined using a polystyrene micro plate assay. In addition, we used the WST-1 assay
to determine the cytotoxicity of the RCE on HGF, Ca9-22 and KB cells.
Results: The RCE had antibacterial activity against oral bacteria used in this study. In
particular, most signiﬁcant antibacterial activity was observed against Fusobacterium
nucleatum, Prevotella intermedia and Porphyromonas gingivalis. The MIC and mini-
mum bactericidal concentration were 7.2 mg/mL–28.8 mg/mL and 14.4 to >57.6 mg/mL.
The RCE had an inhibitory effect on bioﬁlm formation at the MIC and sub-MIC levels. In
addition, the RCE had low cytotoxic effects on HGF, Ca9-22 and KB cells.
Conclusions: Thus, our results indicate that the RCE may be used for preventing oral
diseases.1. Introduction
Dental caries and periodontitis have become a global health
problem. Streptococcus mutans (S. mutans), a gram-positive
coccus, is the causative agent of dental caries; however, other
bacteria, including Lactobacillus and Actinomyces may be
involved in human dental caries. These species adhere and
accumulate on the tooth surface by producing extracellular
polysaccharides from sucrose in the oral cavity. This speciﬁccharacteristic of the bacterial species is essential for the formation
and development of the bioﬁlm [1,2]. Speciﬁc bacteria isolated
from human dental bioﬁlm such as Porphyromonas gingivalis
(P. gingivalis), Prevotella intermedia (P. intermedia),
Fusobacterium nucleatum (F. nucleatum), and Aggregatibacter
actinomycetemcomitans (A. actinomycetemcomitans) induce
periodontitis [3]. These infections can be prevented by
mechanical removal of the oral bioﬁlm by brushing the teeth
and ﬂossing. However, some individuals, particularly children
and elderly, may not be able to achieve mechanical removal of
the bioﬁlm [4].
Chlorhexidine (CHX) is generally accepted as the standard
antibioﬁlm agent in the ﬁeld of dentistry. However, the use CHX
not only remains controversial but also has adverse effects,
including staining of teeth, detrimental effect on vital tissues and
development of hypersensitivity reactions [2,5,6]. Therefore,le under the CC BY-NC-ND license (http://
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ability of bioﬁlm formation of bacteria is required as one of
the strategies for the prevention of dental caries and
periodontitis.
The use of plant extracts as alternative medical treatments has
become popular in the recent years. The term ‘plant products’
usually refers to secondary metabolites produced by plants.
Typically, these substances serve as the defense mechanism for
the plant against predation by microorganisms, insects, and
herbivores [7]. Hibiscus sabdariffa L (family Malvaceae),
commonly known as roselle or red sorrel in English, is widely
grown in Central and West Africa, Southeast Asia, and other
regions. Roselle is an annual, erect, bushy, 2.4 m tall
herbaceous subshrub. It grows widely in the tropical and
subtropical areas. The thick, red and ﬂeshy, cup-shaped part of
the ﬂower is known as calyx; the calyx has been used worldwide
in cold and hot beverages, puddings and jellies, etc [8–10].
Roselle calyx is rich in secondary metabolites, which have
medicinal properties. Previous studies have shown that the
calyces contain ﬂavonoids such as gossypetin, hibiscetin, sab-
daretine, alkaloids, and saponins [11,12]. In addition, roselle
extract contains hibiscus acid, hydroxybenzoic acids,
ﬂavonols, anthocyanins and other polyphenolic compounds
[13]. Roselle extract has been used in folk medicine. The
extract has antihypertensive [14], hepatoprotective [15],
antihyperlipidemic [16], antioxidant [17], anticancer [18], anti-
inﬂammatory [19], antimicrobial properties [12,20]. Although
there were studies reporting the effects of roselle as an herbal
medicine, to date, only a few studies have examined the
effects of roselle calyx extract (RCE) as an antibacterial agent,
particularly in the ﬁeld of dentistry. Thus, the purpose of our
study was to investigate the effects of RCE on oral pathogenic
bacteria, particularly the antibacterial effect on target
organisms, inhibition of bioﬁlm formation, and cytotoxic
effect on human oral cells.
2. Materials and methods
2.1. Preparation of RCE
Plant material was collected and identiﬁed by the Central
Research and Development of Medicinal Plant and Traditional
Medicine, Tawangmangu, Central Java, Indonesia. A total of
16 g roselle calyx powder was soaked in 160 mL ethyl alcohol
(Wako Pure Chemical Industries Ltd) with shaking for 24 h at
room temperature. After centrifugation, the extract was lyophi-
lized. Then, the extract was dissolved in phosphate-buffered
saline (PBS), the pH was adjusted to 7.0, and the extract was
aseptically ﬁltered through a disposable membrane ﬁlter unit
with a 0.45 mm pore size. The extract was stored in the freezer
at −20 C for the further experiments.
2.2. Bacterial strains and culture conditions
The bacteria used in this study were S. mutans Ingbritt,
Streptococcus sanguinis (S. sanguinis) ATCC 10556T, Lacto-
bacillus casei (L. casei) ATCC 4646, Actinomyces naeslundii
(A. naeslundii) ATCC 12104T, A. actinomycetemcomitans
ATCC 29522, F. nucleatum JCM 6328, P. gingivalis ATCC
33277T and P. intermedia ATCC 25611T. S. mutans,
S. sanguinis, and L. casei were cultured in trypticase soy (TY;Difco, Detroit, MI, USA) agar supplemented with yeast extract
(1 mg/mL). Brain-heart infusion-blood agar supplemented with
hemin (BHI-HM) (10 mg/mL; Sigma, St Louis, MO, USA), and
menadione (5 mg/mL; Sigma) was used to culture A. naeslundii,
A. actinomycetemcomitans, F. nucleatum, P. gingivalis, and
P. intermedia. All strains were cultured under anaerobic con-
ditions (85% N2, 10% H2, and 5% CO2) at 37 C for 72 h.
2.3. Antibacterial activity test
The colonies of bacteria cultured under anaerobic conditions
for 3 d in TY/BHI-HM agar were suspended in PBS. The sus-
pension was centrifuged (15000 rpm, 4 C, 5 min), washed, and
diluted in PBS to obtain 107 cfu/mL. Then, a 500 mL aliquot of
the bacterial suspension was centrifuged, and the pellets were
treated with 250 mL of RCE at a concentration of 144 mg/mL or
PBS as a control for 10 or 20 min. Subsequently, the pellets
were washed 3 times and were suspended in PBS. We inoculated
100 mL of the bacterial suspension on an agar plate and incu-
bated it under anaerobic conditions at 37 C for 3 d–5 d. The
numbers of viable bacteria were counted after the incubation
period. The percentage of viable bacteria was determined as a
proportion of control (100%). The experiments were performed
in triplicate for each bacterial species.
2.4. Minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC)
The MIC and MBC were determined using microdilution
methods [21]. Bacteria from overnight culture were adjusted to
an optical density (OD) of 1.0 at 600 nm, and then diluted in
appropriate growth medium. Bacterial suspensions of each
bacterium were plated on 96-well ﬂat-bottom microplates
(Sigma–Aldrich, USA) and were treated with different concen-
trations of the RCE to obtain ﬁnal bacterial concentration of
1 × 105 cfu/mL to 5 × 106 cfu/mL. Then, the plates were
incubated at 37 C in anaerobic conditions for 24 h. The MIC
was deﬁned as the lowest concentration of the extract that
completely inhibits the growth of the bacteria as detected by the
unaided eye. For the determination of the MBC, a 100 mL
aliquot of the bacterial suspension was inoculated on agar plate
from those wells that contained the RCE at the MIC and at
concentrations higher than the MIC. The MBC was deﬁned as
the lowest concentration at which bacteria did not grow on the
agar plate after the incubation period.
2.5. Effect on bioﬁlm formation
The inhibitory effect of different concentrations of the RCE on
the ability to form bioﬁlm was examined by using a polystyrene
micro plate assay. The bacterial suspensions from overnight broth
culture were adjusted to an OD of 1.0 at 600 nm, and then diluted
in BHI-broth supplemented with sucrose 0.5%–2% (S. mutans,
S. sanguinis, A. naeslundii and L. casei), BHI-broth
(A. actinomycetemcomitans) or GAM-broth (P. gingivalis,
P. intermedia, and F. nucleatum). Thereafter, the bacterial sus-
pensions were treated with different concentrations of extract or
PBS as a control in 96-well ﬂat-bottom micro plate. The ﬁnal
concentration of bacteria was 1 × 105 cfu/mL to 5 × 106 cfu/mL.
The plates were then incubated in anaerobic condition for
designated times appropriate for each bacterium (16 h–72 h).
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Figure 1. Effect of RCE on the viability of oral pathogenic bacteria.
S. m: S. mutans, S. s: S. sanguinis, L. c: L. casei, A. n: A. naeslundii, A. a:
A. acetemcomitans, P. g: P. gingivalis, P. i: P. intermedia, F. n:
F. nucleatum. The viable bacteria were expressed as percent of control.
*P < 0.05, **P < 0.01: signiﬁcantly different from the control.
Table 1
MIC and MBC of RCE against eight oral pathogenic bacteria.
Bacterial species MIC (mg/mL) MBC (mg/mL)
S. mutans 7.2 57.6
S. sanguinis 28.8 57.6
L. casei 28.8 >57.6
A. naeslundii 14.4 >57.6
A. actinomycetemcomitans 28.8 57.6
F. nucleatum 7.2 14.4
P. gingivalis 7.2 28.8
P. intermedia 14.4 28.8
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were gently washed with PBS and air-dried. The bioﬁlm formed
on the bottom of the plate was stained with 50 mL of 0.1% crystal
violet for 15 min at room temperature, and the wells were gently
washed and bound dye was extracted by adding 200 mL of ethyl
alcohol. The amount of bioﬁlm formed was quantiﬁed by
measuring the resulting ethyl alcohol solution at 595 nm on a
microtiter plate reader TECAN Inﬁnite TM 200 (Tecan
Deutschland GmbH, Crailsheim, Germany). The inhibitory effect
of RCE on bioﬁlm formation was determined as a proportion of
control (100%). All experiments were performed in triplicate.
2.6. Cytotoxicity
Human gingival ﬁbroblast and human mouth epithelial cells
(Ca9-22 and KB cells) were grown in Dulbecco's modiﬁed
Eagle's medium (DMEM, Sigma–Aldrich) supplemented with
10% fetal bovine serum, penicillin (100 U/mL), streptomycin
(100 mg/mL), and amphotericin B (100 mg/mL). The cells were
cultured at 37 C in a 5% CO2 incubator to obtain 90%–100%
conﬂuence and used at 3 passages–10 passages. After washing
with PBS, the cells were detached from the culture plate by
treatment with 0.05% trypsin-EDTA (GIBCO). The cells were
counted using a haemocytometer (EKDS, Tokyo), and then
diluted to obtain 1 × 105 mL. A 100 mL of the cell suspension
was cultured in a 96-well plate and incubated it for 24 h at 37 C
in a CO2 incubator. Then, the cells were treated with
100 mLRCE, CHX, or PBS for 20 min. For measurement of
viable cells, 10 mL of water-soluble tetrazolium salt, 4-[3-(4-
iodophenyl)-2-(4-nitrophenyl)-2//-5-tetrazolio]-1, 3-benzene
disulfonate (WST-1, Roche, Germany) was added to the cells.
They were incubated for 30–60 min at 37 C in a CO2 incubator,
and then the absorbance of each well was measured by using
microtiter plate reader at a wavelength of 450 nm. Viable cells
were evaluated as follows: [(OD450 of treated cells and reagent
– OD450 of reagent without cell)/(OD450 control cells and re-
agent – OD450 of reagent without cell)] × 100. The decrease in
viable cells was expressed as a percentage of control. All ex-
periments were performed in triplicate.
2.7. Statistical analysis
Statistical analysis was performed using SPSS 21 software.
Results were obtained in triplicates and were expressed as
mean ± standard deviation. The signiﬁcance of the differences
between groups was determined using independent t-test with a
value of P < 0.05–0.01.
3. Results
3.1. Antibacterial activity
The results of the effects of the RCE on bacterial viability
were shown in Figure 1. The numbers of viable bacteria in the
RCE group were signiﬁcantly lower than those in the control
group. The numbers of almost all the bacteria, except those of
S. sanguinis, L. casei, and A. naeslundii, decreased by more than
50% after treatment with the RCE for 10 min. Treatment with
the RCE for 20 min decreased the numbers of all bacteria by
more than 50%. The RCE had the strongest activity on
F. nucleatum, P. intermedia, and P. gingivalis. The number ofviable bacteria decreased by more than 90% (P < 0.05) at
treatment times of 10 and 20 min.
3.2. MIC and MBC
The RCE (pH 7.0) showed bacteriostatic and bactericidal
effects against eight oral pathogenic bacteria. The MIC and
MBC values were shown in Table 1. The MIC ranged from
7.2 mg/mL to 28.8 mg/mL and the MBC ranged from 14.4 mg/
mL to more than 57.6 mg/mL. S. mutans, F. nucleatum, and
P. gingivalis were the most sensitive bacteria (MIC = 7.2 mg/
mL). The least sensitive bacteria were S. sanguinis, L. casei, and
A. actinomycetemcomitans (MIC = 28.8 mg/mL).
3.3. Effect on bioﬁlm formation
The effect of the RCE on the formation of bioﬁlm by
S. mutans, S. sanguinis, L. casei, A. naeslundii,
A. actinomycetemcomitans, P. gingivalis, P. intermedia and
F. nucleatum was shown in Figure 2. RCE at the MIC and sub-
MIC levels were used in these experiments. RCE inhibited
bioﬁlm formation by S. mutans, A. naeslundii, P. gingivalis,
P. intermedia and F. nucleatum at concentration of 0.9 mg/mL
(P < 0.01), that by L. casei at 1.8 mg/mL (P < 0.01), and that by
S. sanguinis and A. actinomycetemcomitans at 7.2 mg/mL
(P < 0.01–0.05). The 50% inhibitory concentration of RCE on
bioﬁlm formation was 0.9 mg/mL for S. mutans, A. naeslundii,
P. intermedia, P. gingivalis and F. nucleatum; 7.2 mg/mL for
0%
20%
40%
60%
80%
100%
control 0.9 1.8 3.6 7.2
B
io
fil
m
 fo
rm
at
io
n 
(%
 o
f c
on
tro
l)
Concentration of RCE (mg/mL)
A
**
** ** **
0%
20%
40%
60%
80%
100%
120%
B
io
fil
m
 fo
rm
at
io
n
(%
 o
f c
on
tro
l)
Concentration of RCE (mg/mL)
*
* *
B
0%
20%
40%
60%
80%
100%
120%
B
io
fil
m
 fo
rm
at
io
n
(%
 o
f c
on
tro
l)
Concentration of RCE (mg/mL)
C
**
**
**
0%
20%
40%
60%
80%
100%
120%
140%
B
io
fil
m
 fo
rm
at
io
n
(%
 o
f c
on
tro
l)
Concentration of RCE (mg/mL)
0%
20%
40%
60%
80%
100%
120%
control 0.9 1.8 3.6 7.2
B
io
fil
m
 fo
rm
at
io
n
(%
 o
f c
on
tro
l)
Concentration of RCE (mg/mL)
**
**
F
0%
20%
40%
60%
80%
100%
B
io
fil
m
 fo
rm
at
io
n
(%
 o
f c
on
tro
l)
Concentration of RCE (mg/mL)
**
** ** ** **
D
0%
20%
40%
60%
80%
100%
B
io
fil
m
 fo
rm
at
io
n
(%
 o
f c
on
tro
l)
Concentration of RCE (mg/mL)
** ** ** **
**
G
0%
20%
40%
60%
80%
100%
B
io
fil
m
 fo
rm
at
io
n
(%
 o
f c
on
tro
l)
Concentration of RCE (mg/mL)
H
**
** **
**
E
**
*
** ** **
** **
Figure 2. Inhibitory effect of RCE on bioﬁlm formation.
A: S. mutans, B: S. sanguinis, C: L. casei, D: A. naeslundii, E: A. acetemcomitans, F: P. gingivalis, G: P. intermedia, and H: F. nucleatum. Experiment used
RCE at MIC and sub-MIC levels in triplicate. The bioﬁlm formation was performed as percent of control. *P < 0.05, **P < 0.01: signiﬁcantly different from
the control.
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S. sanguinis.
3.4. Cytotoxicity
To determine the cytotoxic effects caused by the RCE, we
determined the viability of cells from the oral cavity by using
WST-1 assay. Cell viability of all cell lines used in this study
was 60% after treatment with the RCE for 20 min (Figure 3).
HGF cells showed the highest viability (82.9%), whereasFigure 3. Cytotoxicity of RCE on human oral cells.
Control: PBS, CHX: 0.05%, RCE: 144 mg/mL. The viable cells were
performed as percent of control. *P < 0.05: signiﬁcantly different from the
control.Ca9-22 cells showed the lowest viability (60.9%). Our results
showed that the RCE was less cytotoxic to oral cells. No sta-
tistically signiﬁcant differences were observed between the
viability of HGF, Ca9-22, and KB cells and the control cells
(P > 0.05). Thus, the percentage of viable cells in the RCE-
treated group was not signiﬁcantly different from that of con-
trol group. However, the viability of cells treated with CHX was
signiﬁcantly different from that of the control cells (P < 0.05).
4. Discussion
CHX is widely used in mouthwashes for the prevention and
treatment of oral diseases because it can inhibit the growth of
oral pathogenic bacteria. However, CHX is cytotoxic to human
periodontal cells, inhibits protein synthesis, affects mitochon-
drial activity, and thus, has adverse effects on vital tissues [5].
Therefore, it is important to ﬁnd the alternative agents that are
less cytotoxic and can be used for prevention of oral diseases.
In this study, we used the extract of roselle calyx, a plant that
is known to have many medicinal properties.
We found that RCE had bactericidal activity against both
cariogenic and periodontopathic bacteria. RCE showed strongest
inhibitory activity against F. nucleatum, P. intermedia and
P. gingivalis, which indicated that RCE was more effective
against gram-negative bacteria than gram-positive bacteria. The
difference in the effect of RCE on gram-negative bacteria and
gram-positive bacteria may be because of the differences in the
bacterial cell wall structure. The peptidoglycan layer in the cell
Herastuti Sulistyani et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(2): 119–124 123wall of gram-positive bacteria is thicker than that in the gram-
negative bacteria, which inhibits the RCE from entering the
cell membrane of gram-positive bacteria [21]. The MBC of RCE
was different for gram-negative and gram-positive bacteria; the
MBC was 14.4 mg/mL–57.6 mg/mL and 57.6 mg/mL to
>57.6 mg/mL, respectively. Our results are consistent with those
of a previous study, which showed that the roselle extract had
the highest zone of inhibition for Escherichia coli, a non-oral
gram-negative bacterium [22]. The antibacterial activity
observed in our study may be because of the main compound
in the RCE, such as ﬂavonoids. Flavonoids have the ability to
bind with bacterial cell walls. In addition, with the number of
hydroxyl groups present on the phenolic ring increase because
of hydroxylation, which in turn leads to increase in the
antimicrobial activity [7].
Among the gram-negative bacteria,A. actinomycetemcomitans
was the least sensitive against RCE; the MIC of
A. actinomycetemcomitans approached to the MIC of the gram-
positive bacteria. This ﬁnding was also reported in a previous
study. A. actinomycetemcomitans was less sensitive than
P. intermedia, P. gingivalis and F. nucleatum to garlic extract [23].
Moreover, A. actinomycetemcomitans was less sensitive to a
combination of metronidazole and amoxicillin [24]. These
bacteria may modulate the aspect of virulence factor and control
cellular adaption to growth under limiting conditions [25].
Oral bioﬁlm plays in important role in the pathogenesis of
oral diseases, and the inhibiting the bioﬁlm formation is one of
the approaches for preventing oral diseases. For determining the
effect of RCE on bioﬁlm formation, the extract at sub-MIC level
is used. Thus, the decrease of the amount of bioﬁlm formed is
not because of the inhibition of bacterial growth, but because of
the inability of the bacteria to form bioﬁlm. Our results showed
that RCE at sub-MICs level could inhibit the formation of bio-
ﬁlm by eight bacteria in a dose-dependent manner. Although the
mechanisms underlying the inhibitory effects of RCE on the
ability to form bioﬁlm are still unknown, the inhibitory effects
may be due to ﬂavonoid and tannins present in the RCE. The
inhibitory effects of the extract on bioﬁlm formation depend on
the phenolic compounds present in the extract, because these
compounds bind strongly to proteins and the enzymes, thus the
bacteria are unable attached to the tooth surface. Adhesion and
colonization are very important steps for bioﬁlm formation [2].
We showed that the RCE at sub-MIC levels signiﬁcantly
inhibited bioﬁlm formation by gram-positive and gram-negative
bacteria. The effects of RCE on bioﬁlm produced by a mixed
culture of bacteria should be examined in future studies.
During the development of novel agents as oral care prod-
ucts, their toxic effects on human oral cells should be carefully
examined. An ideal oral care product should be an efﬁcient
antimicrobial agent but should not be toxic to human oral cells.
Our results showed that the viability of HGF, Ca9-22 and KB
cells treated with RCE was not signiﬁcantly different from that
of control cells. Thus, RCE is safe to be used as an oral care
product. Our ﬁndings are consistent with those reported previous
study, which showed that the RCE was safe in brine shrimps
lethality assay [12].
CHX is chemical substance with excellent antimicrobial ac-
tion. It is active against a wide range of microorganisms.
However, a previous study showed that CHX at a concentration
of more than 0.05% completely inhibits protein synthesis in
human periodontal ligament cells. Thus, CHX may cause
detrimental effects on vital tissues [5]. In addition, our studyshowed that CHX has cytotoxic effect against HGF, Ca9-22
and KB cells. These results indicate that RCE is safer than
CHX as an oral care product.
Our results indicate that RCE exerts antibacterial activity
against gram-positive and gram-negative bacteria, with a strong
activity against gram-negative bacteria. Moreover, at sub-MIC
levels, RCE inhibits the formation of bioﬁlm by gram-positive
and gram-negative bacteria. In particular, RCE has lower cyto-
toxicity than CHX, a product widely used as mouthwashes.
Therefore, because of the favorable bioactivity and a simple
process involved in producing the extract from the plant, RCE
has a high potential to be used as a novel agent for preventing
oral diseases. Further studies are required to investigate the ef-
fects of RCE in clinical practice and to examine the complexity
of life span of oral bacteria in natural environments.
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